American Journal of Kidney Diseases
Volume 50, Issue 6 , Pages 908-917 , December 2007

Changing the Timing of Antihypertensive Therapy to Reduce Nocturnal Blood Pressure in CKD: An 8-Week Uncontrolled Trial

  • Roberto Minutolo, MD, PhD

      Affiliations

    • Department of Nephrology, Second University of Naples, Naples, Italy
    • Corresponding Author InformationAddress correspondence to Roberto Minutolo, MD, PhD, Department of Nephrology, Second University of Naples, Via Tiberio 90 I-80125, Naples, Italy.
    • ,
  • Francis B. Gabbai, MD

      Affiliations

    • Department of Nephrology, University of California at San Diego Medical School, San Diego, CA.
    • ,
  • Silvio Borrelli, MD

      Affiliations

    • Department of Nephrology, Second University of Naples, Naples, Italy
    • ,
  • Raffaele Scigliano, MD

      Affiliations

    • Department of Nephrology, Second University of Naples, Naples, Italy
    • ,
  • Paolo Trucillo, MD

      Affiliations

    • Department of Nephrology, Second University of Naples, Naples, Italy
    • ,
  • Diego Baldanza, MD

      Affiliations

    • Department of Nephrology, Second University of Naples, Naples, Italy
    • ,
  • Simona Laurino, MD

      Affiliations

    • Department of Nephrology, Second University of Naples, Naples, Italy
    • ,
  • Sara Mascia, MD

      Affiliations

    • Department of Nephrology, Second University of Naples, Naples, Italy
    • ,
  • Giuseppe Conte, MD

      Affiliations

    • Department of Nephrology, Second University of Naples, Naples, Italy
    • ,
  • Luca De Nicola, MD, PhD

      Affiliations

    • Department of Nephrology, Second University of Naples, Naples, Italy

Received 9 May 2007 ,Accepted 18 July 2007.

References 

  1. De Nicola L, Minutolo R, Chiodini P, et al. TArget Blood Pressure LEvels in Chronic Kidney Disease (TABLE in CKD) Study Group Global approach to cardiovascular risk in chronic kidney disease: Reality and opportunities for intervention. Kidney Int. 2006;69:538–545
  2. National Kidney Foundation. K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease. Am J Kidney Dis. 2004;43(suppl 1):S1–S290
  3. Bakris GL, Weir MR, Shanifar S, et al. RENAAL Study Group Effects of blood pressure level on progression of diabetic nephropathy (Results from the RENAAL Study). Arch Intern Med. 2003;163:1555–1565
  4. Jafar TH, Stark PC, Schmid CH, et al. AIPRD Study Group Progression of chronic kidney disease: The role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition. Ann Intern Med. 2003;139:244–253
  5. Bakris GL, Williams M, Dworkin L, et al. Preserving renal function in adults with hypertension and diabetes: A consensus approach: National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis. 2000;36:646–661
  6. De Nicola L, Minutolo R, Bellizzi V, et al. TABLE in CKD Study Group Achievement of target blood pressure levels in chronic kidney disease: A salty question?. Am J Kidney Dis. 2004;43:782–795
  7. De Nicola L, Minutolo R, Gallo C, et al. TArget Blood Pressure LEvels in Chronic Kidney Disease (TABLE in CKD) Study Group Management of hypertension in chronic kidney disease: The Italian Multicentric Study. J Nephrol. 2005;18:397–404
  8. Peralta CA, Hicks LS, Chertow GM, et al. Control of hypertension in adults with chronic kidney disease in the United States. Hypertension. 2005;45:1119–1124
  9. Marìn R, Fernandez-Vega F, Gorostidi M, et al. COPARENAL (COntrol de la hiPertension Arterial en pacientes con insuficiencia RENAL) Study Investigators Blood pressure control in patients with chronic renal insufficiency in Spain: A cross-sectional study. J Hypertens. 2006;24:395–402
  10. Minutolo R, Sasso FC, Chiodini P, et al. Management of cardiovascular risk factors in advanced type 2 diabetic nephropathy: A comparative analysis in nephrology, diabetology and primary care settings. J Hypertens. 2006;24:1655–1661
  11. Thompson AM, Pickering TG. The role of ambulatory blood pressure monitoring in chronic and end-stage renal disease. Kidney Int. 2006;70:1000–1007
  12. Agarwal R, Andersen MJ. Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease. Kidney Int. 2006;69:1175–1180
  13. Ohkubo T, Hozawa A, Yamaguchi J, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: The Ohasama study. J Hypertens. 2002;20:2183–2189
  14. Staessen JA, Thijs L, Fagard R, et al. Predicting cardiovascular risk using conventional vs. ambulatory blood pressure in older patients with systolic hypertension. JAMA. 1999;282:539–546
  15. Minutolo R, Borrelli S, Scigliano R, et al. Prevalence and clinical correlates of white coat hypertension in chronic kidney disease. Nephrol Dial Transplant. 2007;22:2217–2223
  16. Farmer CK, Goldsmith DJ, Cox J, Dallyn P, Kingswood JC, Sharpstone P. An investigation of the effect of advancing uraemia, renal replacement therapy and after renal transplantation on blood pressure diurnal variability. Nephrol Dial Transplant. 1997;12:2301–2307
  17. Sachdeva A, Weder AB. Nocturnal sodium excretion, blood pressure dipping and sodium sensitivity. Hypertension. 2006;48:527–533
  18. Agarwal R, Andersen MJ. Blood pressure recordings within and outside the clinic and cardiovascular events in chronic kidney disease. Am J Nephrol. 2006;26:503–510
  19. Timio M, Venanzi S, Lolli S, et al. “Non dipper” hypertensive patients and progressive renal insufficiency: A 3-year longitudinal study. Clin Nephrol. 1995;43:382–387
  20. Farmer CK, Goldsmith DJ, Quin JD, et al. Progression of diabetic nephropathy—Is diurnal blood pressure rhythm as important as absolute blood pressure level?. Nephrol Dial Transplant. 1998;13:635–639
  21. Csiky B, Kovacs T, Wagner L, Vass T, Nagy J. Ambulatory blood pressure monitoring and progression in patients with IgA nephropathy. Nephrol Dial Transplant. 1999;14:86–90
  22. Davidson MB, Hix JK, Donald G, Brotman DJ. Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate. Arch Intern Med. 2006;166:846–852
  23. Hermida RC, Smolensky MH. Chronotherapy of hypertension. Curr Opin Nephrol Hypertens. 2004;13:501–505
  24. Hermida RC, Ayala DE, Calvo C. Administration-time-dependent effects of antihypertensive treatment on the circadian pattern of blood pressure. Curr Opin Nephrol Hypertens. 2005;14:453–459
  25. Hermida RC, Calvo C, Ayala DE, et al. Administration-time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects. Hypertension. 2003;42:283–290
  26. O’Brien E, Asmar R, Beilin L, et al. European Society of Hypertension Working Group on Blood Pressure Monitoring European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens. 2003;21:821–848
  27. Dwyer J, Kenler SR. Assessment of nutritional status in renal disease. In:  Mitch WE,  Klahr S editor. Nutrition and the Kidney. (ed 2). Boston, MA: Little, Brown; 1993;p. 61–95
  28. Labrecque G, Beauchamp D. Rhythms and pharmacokinetics. In:  Redfern P editors. Chronotherapeutics. London: Pharmaceutical Press; 2003;p. 75–110
  29. Qiu YG, Zhu JH, Tao QM, et al. Captopril administered at night restores the diurnal blood pressure rhythm in adequately controlled, nondipping hypertensives. Cardiovasc Drugs Ther. 2005;19:189–195
  30. Portaluppi F, Vergnani L, Manfredini R, et al. Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure. Am J Hypertens. 1998;8:719–726
  31. Bakris GL, Williams M, Dworkin L, et al. Preserving renal function in adults with hypertension and diabetes: A consensus approach: National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis. 2000;36:646–661
  32. Hermida RC, Ayala DE, Calvo C, et al. Effect of time of day of treatment on ambulatory blood pressure pattern of patients with resistant hypertension. Hypertension. 2005;46:1053–1059
  33. Uzu T, Ishikawa K, Fujii T, Nakamura S, Inenaga T, Kimura G. Sodium restriction shifts circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation. 1997;96:1859–1862
  34. Fukuda M, Munemura M, Usami T, et al. Nocturnal blood pressure is elevated with natriuresis and proteinuria as renal function deteriorates in nephropathy. Kidney Int. 2004;65:621–625
  35. Cianciaruso B, Bellizzi V, Minutolo R, et al. Renal adaptation to dietary sodium restriction in moderate renal failure resulting from chronic glomerular disease. J Am Soc Nephrol. 1996;7:306–313
  36. Lakatta EG, Levy D. Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises. Part I. Aging arteries: A “set up” for vascular disease. Circulation. 2003;107:139–146
  37. Higashi Y, Nakagawa K, Kimura M, et al. Circadian variation of blood pressure and endothelial function in patients with essential hypertension: A comparison of dippers and non-dippers. J Am Coll Cardiol. 2002;40:2039–2043
  38. Hermida RC, Calvo C, Ayala DE, Lopez JE. Decrease in urinary albumin excretion with normalization of nocturnal blood pressure in hypertensive patients. Hypertension. 2005;46:960–968
  39. Yoshioka T, Rennke HG, Salant DJ, et al. Role of abnormally high transmural pressure in the permselectivity defect of glomerular capillary wall: A study in early passive Heymann nephritis. Circ Res. 1987;61:531–538
  40. Weir MR, Fink JC. Salt intake and progression of chronic kidney disease: An overlooked modifiable exposure? (A commentary). Am J Kidney Dis. 2005;45:176–188
  41. Klosa N, Bakris G. Lessons learned from recent hypertension trials about kidney disease. Clin J Am Soc Nephrol. 2006;1:229–235

 Originally published online as doi:10.1053/j.ajkd.2007.07.020 on September 21, 2007.

PII: S0272-6386(07)01127-4

doi: 10.1053/j.ajkd.2007.07.020

American Journal of Kidney Diseases
Volume 50, Issue 6 , Pages 908-917 , December 2007

Article Tools

* Image Usage & Resolution